XML 42 R25.htm IDEA: XBRL DOCUMENT v3.25.0.1
Shareholders' Equity
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Equity
Authorized Shares
We are authorized to issue an aggregate of 60,000,000 shares, all of which are designated as Common Stock having a par value of $0.375 per share. The Board of Directors is authorized to establish one or more series of preferred stock, setting forth the designation of each such series, and fixing the relative rights and preferences of each such series.
Accumulated Other Comprehensive Loss
The changes in components of accumulated other comprehensive loss, net of tax, were as follows:
Foreign Currency Translation
Adjustments		Pension and Postretirement
Medical Benefits		Derivative Financial InstrumentsUnrealized Gain on Debt SecuritiesTotal
December 31, 2022$(53.9)$2.7 $1.0 $— $(50.2)
Other comprehensive (loss) income before reclassifications9.3 1.0 0.6 — 10.9 
Amounts reclassified from accumulated other comprehensive loss(1.0)— (2.0)— (3.0)
Net current period other comprehensive (loss) income8.3 1.0 (1.4)— 7.9 
December 31, 2023$(45.6)$3.7 $(0.4)$— $(42.3)
Other comprehensive (loss) income before reclassifications(28.6)(0.9)2.0 0.2 (27.3)
Amounts reclassified from accumulated other comprehensive loss(1.0)— (2.1)— (3.1)
Net current period other comprehensive (loss) income(29.6)(0.9)(0.1)0.2 (30.4)
December 31, 2024$(75.2)$2.8 $(0.5)$0.2 $(72.7)
Accumulated other comprehensive loss associated with pension and postretirement benefits, derivative financial instruments, and unrealized gain on debt securities is included in Notes 13, 11 and 9, respectively.
Repurchase of Common Stock
On October 31, 2016, the Board of Directors authorized the repurchase of 1,000,000 shares of our common stock. On February 11, 2025, the Board of Directors authorized the repurchase of up to 2,000,000 shares. Our stock repurchase program is not subject to an expiration date.
During the year ended December 31, 2024, the Company paid $19.6 million to repurchase 198,352 shares of its common stock at an average price of $98.92 per share. As of December 31, 2024, 623,061 shares were available to be repurchased. The Company paid $21.7 million to repurchase 290,920 shares during the year ended December 31, 2023.